Palatin Technologies Inc (PTN)
1.86
+0.07
(+3.91%)
USD |
NYAM |
Apr 30, 16:00
1.85
-0.01
(-0.54%)
After-Hours: 20:00
Palatin Technologies Accounts Receivable (Quarterly): 2.346M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.346M |
September 30, 2023 | 1.348M |
June 30, 2023 | 2.916M |
March 31, 2023 | 1.699M |
December 31, 2022 | 1.807M |
September 30, 2022 | 2.023M |
June 30, 2022 | 1.78M |
March 31, 2022 | 0.79M |
December 31, 2021 | 0.584M |
September 30, 2021 | 0.914M |
June 30, 2021 | 1.580M |
March 31, 2021 | 1.869M |
December 31, 2020 | 4.747M |
September 30, 2020 | 5.044M |
June 30, 2020 | |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.118M |
September 30, 2019 | 0.0974M |
June 30, 2019 | 60.27M |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | 0.1042M |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
Date | Value |
---|---|
September 30, 2017 | 9.390M |
June 30, 2017 | 15.12M |
March 31, 2017 | 4.658M |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | 0.00 |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | 3.035M |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.038M |
September 30, 2012 | 0.0314M |
June 30, 2012 | 0.0276M |
March 31, 2012 | 0.0166M |
December 31, 2011 | 1.068M |
September 30, 2011 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2020
60.27M
Maximum
Jun 2019
4.996M
Average
1.740M
Median
Accounts Receivable (Quarterly) Benchmarks
Oragenics Inc | -- |
Outset Medical Inc | 32.98M |
Ligand Pharmaceuticals Inc | 32.92M |
Galectin Therapeutics Inc | -- |
ADMA Biologics Inc | 27.42M |